Announcements Trials
Browse Landscape

Phase

Phase NA 5Phase 3 4Phase 2 3Phase 1 3Phase 2/3 1Phase 1/2 1

Status

Completed 3Active not recruiting 1

Sponsor Class

NETWORK 3NIH 1

Study Type

Interventional 4

Sponsor

Cancer Type

Gynecologic 4

Conditions

Nasopharyngeal Carcinoma 26Prostatic Neoplasms 8Squamous Cell Carcinoma of Head and Neck 7Nasopharyngeal Neoplasms 6Head and Neck Neoplasms 6Breast Neoplasms 5Uterine Cervical Neoplasms 4Oropharyngeal Neoplasms 3Lung Neoplasms 3Carcinoma, Non-Small-Cell Lung 3Tongue Neoplasms 2Salivary Gland Neoplasms 2Radiation Injuries 2Neurotoxicity Syndromes 2Hypopharyngeal Neoplasms 2Glioblastoma 2Carcinoma 2Brain Neoplasms 2Astrocytoma 2Vaginal Neoplasms 1Thoracic Neoplasms 1Stage II Prostate Adenocarcinoma AJCC v7 1Sarcoma 1Precancerous Conditions 1Postoperative Complications 1Papillomavirus Infections 1Pancreatic Intraductal Neoplasms 1Pancreatic Adenocarcinoma 1Ototoxicity 1Oligodendroglioma 1

Interventions

Cisplatin 53Paclitaxel 27Carboplatin 22Brachytherapy 18Radiotherapy 17human papillomavirus vaccine, L1 type 16, 18 12Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18 12Gemcitabine 12Topotecan 8Vaccines, Synthetic 7Platinum 7Papillomavirus Vaccines 7Radiation 6Bevacizumab 61,2-diaminocyclohexaneplatinum II citrate 6Neoadjuvant Therapy 5Chemotherapy, Adjuvant 5pembrolizumab 4Vinorelbine 4Radiotherapy, Intensity-Modulated 4Pemetrexed 4Drug Therapy 4Taxes 3Surgical Procedures, Operative 3Ondansetron 3Irinotecan 3Dexamethasone 3Chemoradiotherapy 3tisotumab vedotin 2specific substance maruyama 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Phase 3 × Uterine Cervical Neoplasms × Radiotherapy, Intensity-Modulated × Clear all
NCT02466971 2026-04-13

Testing the Addition of a New Anti-Cancer Drug, Triapine, to the Usual Chemotherapy Treatment (Cisplatin) During Radiation Therapy for Advanced-stage Cervical and Vaginal Cancers

National Cancer Institute (NCI)

Phase 3 Active not recruiting
450 enrolled 11 charts
Gynecologic

Uterine Cervical Neoplasms, Vaginal Neoplasms

NCT00980954 2025-12-31

Chemotherapy and Pelvic Radiation Therapy With or Without Additional Chemotherapy in Treating Patients With High-Risk Early-Stage Cervical Cancer After Radical Hysterectomy

Radiation Therapy Oncology Group

Phase 3 Completed
236 enrolled 28 charts
Gynecologic

Uterine Cervical Neoplasms

NCT01101451 2025-05-23

Radiation Therapy With or Without Chemotherapy in Patients With Stage I-IIA Cervical Cancer Who Previously Underwent Surgery

GOG Foundation

Phase 3 Completed
340 enrolled 13 charts
Gynecologic

Uterine Cervical Neoplasms

NCT01672892 2022-06-15

Standard Versus Intensity-Modulated Pelvic Radiation Therapy in Treating Patients With Endometrial or Cervical Cancer

Radiation Therapy Oncology Group

Phase 3 Completed
289 enrolled 17 charts
Gynecologic

Uterine Cervical Neoplasms, Postoperative Complications, Radiation Injuries, Endometrial Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡